Case study

New studies highlight key benefits of B-NDG mice

Producing CDX and PDX models? See how the B-NDG mouse can assist!

Research models and services

R1310 landing page image

The next generation of highly immunodeficient mice is helping researchers generate PDX and CDX models. One of the most promising new models is the B-NDG mouse.

In one recent study, the B-NDG model was superior to athymic mice in supporting NSCLC human tumor cell growth. This model is ideal for testing anti-cancer agents for their ability to delay tumor growth. Another recent study showed that B-NDG mice were superior to the JAX® NSG™ mice for CDX model development using the Kasumi-1 human tumor cell line.

Complete the form to request our case study and gain more insight.

JAX® is a registered trademark and NSG™ is a trademark of The Jackson Laboratory.

Request the case study